 | • レポートコード：QYR9ST03177 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、糖尿病性網膜症の世界市場について調査・分析し、糖尿病性網膜症の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（レーザー手術、コルチコステロイドの注射、抗VEGF薬の眼への注入、硝子体切除術）、用途別（病院、診療所、検査室、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の糖尿病性網膜症市場動向 ・主要企業別マーケットシェア ・糖尿病性網膜症の種類別市場規模2014-2019 （レーザー手術、コルチコステロイドの注射、抗VEGF薬の眼への注入、硝子体切除術） ・糖尿病性網膜症の用途別市場規模2014-2019 （病院、診療所、検査室、その他） ・糖尿病性網膜症の北米市場：主要企業・種類別/用途別市場規模 ・糖尿病性網膜症のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・糖尿病性網膜症の中国市場：主要企業・種類別/用途別市場規模 ・糖尿病性網膜症の日本国内市場：主要企業・種類別/用途別市場規模 ・糖尿病性網膜症の東南アジア市場：主要企業・種類別/用途別市場規模 ・糖尿病性網膜症のインド市場：主要企業・種類別/用途別市場規模 ・糖尿病性網膜症の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bayer、F. Hoffmann-La Roche、Novartis、Regeneron Pharmaceuticals、 Actavis、Alimera Sciences、Ampio Pharmaceuticals、Antisense Therapeutics、BCN Peptides、Boehringer Ingelheim、Glycadia、iCo Therapeutics、Isis Pharmaceuticals、Kowa Group、Lpath、Numoda Capital、Ohr Pharmaceutical、OPKO Health、Parexel International、Promedior、pSivida、Quark Pharmaceuticals、R-Tech Ueno、Sirnaomics、ThromboGenics ） ・糖尿病性網膜症の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease. Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye, which then collects in the macula. This results in inflammation of tissue and blurry vision.
In 2018, the global Diabetic Retinopathy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Diabetic Retinopathy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Retinopathy development in United States, Europe and China.
The key players covered in this study
Bayer
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Actavis
Alimera Sciences
Ampio Pharmaceuticals
Antisense Therapeutics
BCN Peptides
Boehringer Ingelheim
Glycadia
iCo Therapeutics
Isis Pharmaceuticals
Kowa Group
Lpath
Numoda Capital
Ohr Pharmaceutical
OPKO Health
Parexel International
Promedior
pSivida
Quark Pharmaceuticals
R-Tech Ueno
Sirnaomics
ThromboGenics
Market segment by Type, the product can be split into
Laser surgery
Injection of corticosteroids
Anti-VEGF drugs into the eye
Vitrectomy
Market segment by Application, split into
Hospitals
Clinics and laboratories
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Diabetic Retinopathy status, future forecast, growth opportunity, key market and key players.
To present the Diabetic Retinopathy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Diabetic Retinopathy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Diabetic Retinopathy Market Size Growth Rate by Type (2014-2025)
1.4.2 Laser surgery
1.4.3 Injection of corticosteroids
1.4.4 Anti-VEGF drugs into the eye
1.4.5 Vitrectomy
1.5 Market by Application
1.5.1 Global Diabetic Retinopathy Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics and laboratories
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Diabetic Retinopathy Market Size
2.2 Diabetic Retinopathy Growth Trends by Regions
2.2.1 Diabetic Retinopathy Market Size by Regions (2014-2025)
2.2.2 Diabetic Retinopathy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Diabetic Retinopathy Market Size by Manufacturers
3.1.1 Global Diabetic Retinopathy Revenue by Manufacturers (2014-2019)
3.1.2 Global Diabetic Retinopathy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Diabetic Retinopathy Market Concentration Ratio (CR5 and HHI)
3.2 Diabetic Retinopathy Key Players Head office and Area Served
3.3 Key Players Diabetic Retinopathy Product/Solution/Service
3.4 Date of Enter into Diabetic Retinopathy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Diabetic Retinopathy Market Size by Type (2014-2019)
4.2 Global Diabetic Retinopathy Market Size by Application (2014-2019)
5 United States
5.1 United States Diabetic Retinopathy Market Size (2014-2019)
5.2 Diabetic Retinopathy Key Players in United States
5.3 United States Diabetic Retinopathy Market Size by Type
5.4 United States Diabetic Retinopathy Market Size by Application
6 Europe
6.1 Europe Diabetic Retinopathy Market Size (2014-2019)
6.2 Diabetic Retinopathy Key Players in Europe
6.3 Europe Diabetic Retinopathy Market Size by Type
6.4 Europe Diabetic Retinopathy Market Size by Application
7 China
7.1 China Diabetic Retinopathy Market Size (2014-2019)
7.2 Diabetic Retinopathy Key Players in China
7.3 China Diabetic Retinopathy Market Size by Type
7.4 China Diabetic Retinopathy Market Size by Application
8 Japan
8.1 Japan Diabetic Retinopathy Market Size (2014-2019)
8.2 Diabetic Retinopathy Key Players in Japan
8.3 Japan Diabetic Retinopathy Market Size by Type
8.4 Japan Diabetic Retinopathy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Diabetic Retinopathy Market Size (2014-2019)
9.2 Diabetic Retinopathy Key Players in Southeast Asia
9.3 Southeast Asia Diabetic Retinopathy Market Size by Type
9.4 Southeast Asia Diabetic Retinopathy Market Size by Application
10 India
10.1 India Diabetic Retinopathy Market Size (2014-2019)
10.2 Diabetic Retinopathy Key Players in India
10.3 India Diabetic Retinopathy Market Size by Type
10.4 India Diabetic Retinopathy Market Size by Application
11 Central & South America
11.1 Central & South America Diabetic Retinopathy Market Size (2014-2019)
11.2 Diabetic Retinopathy Key Players in Central & South America
11.3 Central & South America Diabetic Retinopathy Market Size by Type
11.4 Central & South America Diabetic Retinopathy Market Size by Application
12 International Players Profiles
12.1 Bayer
12.1.1 Bayer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Diabetic Retinopathy Introduction
12.1.4 Bayer Revenue in Diabetic Retinopathy Business (2014-2019)
12.1.5 Bayer Recent Development
12.2 F. Hoffmann-La Roche
12.2.1 F. Hoffmann-La Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Diabetic Retinopathy Introduction
12.2.4 F. Hoffmann-La Roche Revenue in Diabetic Retinopathy Business (2014-2019)
12.2.5 F. Hoffmann-La Roche Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Diabetic Retinopathy Introduction
12.3.4 Novartis Revenue in Diabetic Retinopathy Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Regeneron Pharmaceuticals
12.4.1 Regeneron Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Diabetic Retinopathy Introduction
12.4.4 Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2014-2019)
12.4.5 Regeneron Pharmaceuticals Recent Development
12.5 Actavis
12.5.1 Actavis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Diabetic Retinopathy Introduction
12.5.4 Actavis Revenue in Diabetic Retinopathy Business (2014-2019)
12.5.5 Actavis Recent Development
12.6 Alimera Sciences
12.6.1 Alimera Sciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Diabetic Retinopathy Introduction
12.6.4 Alimera Sciences Revenue in Diabetic Retinopathy Business (2014-2019)
12.6.5 Alimera Sciences Recent Development
12.7 Ampio Pharmaceuticals
12.7.1 Ampio Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Diabetic Retinopathy Introduction
12.7.4 Ampio Pharmaceuticals Revenue in Diabetic Retinopathy Business (2014-2019)
12.7.5 Ampio Pharmaceuticals Recent Development
12.8 Antisense Therapeutics
12.8.1 Antisense Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Diabetic Retinopathy Introduction
12.8.4 Antisense Therapeutics Revenue in Diabetic Retinopathy Business (2014-2019)
12.8.5 Antisense Therapeutics Recent Development
12.9 BCN Peptides
12.9.1 BCN Peptides Company Details
12.9.2 Company Description and Business Overview
12.9.3 Diabetic Retinopathy Introduction
12.9.4 BCN Peptides Revenue in Diabetic Retinopathy Business (2014-2019)
12.9.5 BCN Peptides Recent Development
12.10 Boehringer Ingelheim
12.10.1 Boehringer Ingelheim Company Details
12.10.2 Company Description and Business Overview
12.10.3 Diabetic Retinopathy Introduction
12.10.4 Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2014-2019)
12.10.5 Boehringer Ingelheim Recent Development
12.11 Glycadia
12.12 iCo Therapeutics
12.13 Isis Pharmaceuticals
12.14 Kowa Group
12.15 Lpath
12.16 Numoda Capital
12.17 Ohr Pharmaceutical
12.18 OPKO Health
12.19 Parexel International
12.20 Promedior
12.21 pSivida
12.22 Quark Pharmaceuticals
12.23 R-Tech Ueno
12.24 Sirnaomics
12.25 ThromboGenics
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Diabetic Retinopathy Key Market Segments
Table Key Players Diabetic Retinopathy Covered
Table Global Diabetic Retinopathy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Diabetic Retinopathy Market Size Market Share by Type 2014-2025
Figure Laser surgery Figures
Table Key Players of Laser surgery
Figure Injection of corticosteroids Figures
Table Key Players of Injection of corticosteroids
Figure Anti-VEGF drugs into the eye Figures
Table Key Players of Anti-VEGF drugs into the eye
Figure Vitrectomy Figures
Table Key Players of Vitrectomy
Table Global Diabetic Retinopathy Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics and laboratories Case Studies
Figure Others Case Studies
Figure Diabetic Retinopathy Report Years Considered
Table Global Diabetic Retinopathy Market Size 2014-2025 (Million US$)
Figure Global Diabetic Retinopathy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Diabetic Retinopathy Market Size by Regions 2014-2025 (Million US$)
Table Global Diabetic Retinopathy Market Size by Regions 2014-2019 (Million US$)
Table Global Diabetic Retinopathy Market Share by Regions 2014-2019
Figure Global Diabetic Retinopathy Market Share by Regions 2014-2019
Figure Global Diabetic Retinopathy Market Share by Regions 2019
Table Market Top Trends
Table Global Diabetic Retinopathy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Diabetic Retinopathy Market Share by Manufacturers (2014-2019)
Figure Global Diabetic Retinopathy Market Share by Manufacturers in 2018
Table Global Diabetic Retinopathy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Diabetic Retinopathy Product/Solution/Service
Table Date of Enter into Diabetic Retinopathy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
Table Global Diabetic Retinopathy Market Size Share by Type (2014-2019)
Figure Global Diabetic Retinopathy Market Size Market Share by Type (2014-2019)
Table Global Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
Table Global Diabetic Retinopathy Market Size Share by Application (2014-2019)
Figure Global Diabetic Retinopathy Market Size Market Share by Application (2014-2019)
Figure Global Diabetic Retinopathy Revenue Market Share by Application in 2018
Figure United States Diabetic Retinopathy Market Size 2014-2019 (Million US$)
Table United States Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
Table United States Key Players Diabetic Retinopathy Market Share (2018-2019)
Table United States Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
Table United States Diabetic Retinopathy Market Share by Type (2014-2019)
Table United States Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
Table United States Diabetic Retinopathy Market Share by Application (2014-2019)
Figure Europe Diabetic Retinopathy Market Size 2014-2019 (Million US$)
Table Europe Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
Table Europe Key Players Diabetic Retinopathy Market Share (2018-2019)
Table Europe Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
Table Europe Diabetic Retinopathy Market Share by Type (2014-2019)
Table Europe Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
Table Europe Diabetic Retinopathy Market Share by Application (2014-2019)
Figure China Diabetic Retinopathy Market Size 2014-2019 (Million US$)
Table China Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
Table China Key Players Diabetic Retinopathy Market Share (2018-2019)
Table China Diabetic Retinopathy Market Size by Type (2014-20189) (Million US$)
Table China Diabetic Retinopathy Market Share by Type (2014-2019)
Table China Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
Table China Diabetic Retinopathy Market Share by Application (2014-2019)
Figure Japan Diabetic Retinopathy Market Size 2014-2019 (Million US$)
Table Japan Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
Table Japan Key Players Diabetic Retinopathy Market Share (2018-2019)
Table Japan Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
Table Japan Diabetic Retinopathy Market Share by Type (2014-2019)
Table Japan Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
Table Japan Diabetic Retinopathy Market Share by Application (2014-2019)
Figure Southeast Asia Diabetic Retinopathy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Diabetic Retinopathy Market Share (2018-2019)
Table Southeast Asia Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Diabetic Retinopathy Market Share by Type (2014-2019)
Table Southeast Asia Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Diabetic Retinopathy Market Share by Application (2014-2019)
Figure India Diabetic Retinopathy Market Size 2014-2019 (Million US$)
Table India Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
Table India Key Players Diabetic Retinopathy Market Share (2018-2019)
Table India Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
Table India Diabetic Retinopathy Market Share by Type (2014-2019)
Table India Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
Table India Diabetic Retinopathy Market Share by Application (2014-2019)
Figure Central & South America Diabetic Retinopathy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Diabetic Retinopathy Market Share (2018-2019)
Table Central & South America Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
Table Central & South America Diabetic Retinopathy Market Share by Type (2014-2019)
Table Central & South America Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
Table Central & South America Diabetic Retinopathy Market Share by Application (2014-2019)
Table Bayer Company Details
Table Bayer Revenue in Diabetic Retinopathy Business (2014-2019) (Million US$)
Figure Bayer Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
Table Bayer Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
Table Novartis Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
Table Regeneron Pharmaceuticals Recent Development
Table Actavis Company Details
Table Actavis Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
Figure Actavis Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
Table Actavis Recent Development
Table Alimera Sciences Company Details
Table Alimera Sciences Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
Figure Alimera Sciences Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
Table Alimera Sciences Recent Development
Table Ampio Pharmaceuticals Company Details
Table Ampio Pharmaceuticals Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
Figure Ampio Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
Table Ampio Pharmaceuticals Recent Development
Table Antisense Therapeutics Company Details
Table Antisense Therapeutics Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
Figure Antisense Therapeutics Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
Table Antisense Therapeutics Recent Development
Table BCN Peptides Company Details
Table BCN Peptides Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
Figure BCN Peptides Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
Table BCN Peptides Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Glycadia Company Details
Table iCo Therapeutics Company Details
Table Isis Pharmaceuticals Company Details
Table Kowa Group Company Details
Table Lpath Company Details
Table Numoda Capital Company Details
Table Ohr Pharmaceutical Company Details
Table OPKO Health Company Details
Table Parexel International Company Details
Table Promedior Company Details
Table pSivida Company Details
Table Quark Pharmaceuticals Company Details
Table R-Tech Ueno Company Details
Table Sirnaomics Company Details
Table ThromboGenics Company Details
Table Global Diabetic Retinopathy Market Size by Regions (Million US$) 2019-2025
Figure Global Diabetic Retinopathy Market Size Share by Regions (2019-2025)
Figure Global Diabetic Retinopathy Market Size Share by Regions in 2025
Figure United States Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
Figure China Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
Figure India Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
Table Global Diabetic Retinopathy Market Size by Product (2019-2025) (Million US$)
Figure Global Diabetic Retinopathy Market Size by Product (2019-2025)
Figure Global Diabetic Retinopathy Market Size by Product in 2025
Table Global Diabetic Retinopathy Market Size by Application (2019-2025) (Million US$)
Figure Global Diabetic Retinopathy Market Size by Application (2019-2025)
Figure Global Diabetic Retinopathy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場：市場規模・現状・予測 Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…- 糖尿病性網膜症の治療の世界市場：市場規模・現状・予測 Diabetic retinopathy (die-uh-BET-ik ret-ih-NOP-uh-thee) is a diabetes complication that affects eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina).In 2018, the global Diabetic Retinopathy Treatment market size was xx million US$ and it is e…
- 糖尿病注射ペンの世界市場：市場規模・現状・予測 Insulin Pen Needles are used in conjunction with an Insulin pen for the injection of insulin. They come in a variety of needle lengths and diameters and are individually wrapped to keep them sterile.Diabetic Insulin pens resembles that of a pen, one use to write. There working is similar to that of …
- 世界の糖尿病注射ペン市場：専門的調査 Diabetic injection pen are used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose. The gl…
- 糖尿病性胃不全麻痺の治療の世界市場：市場規模・現状・予測 Delayed gastric emptying associated with diabetes is known as Diabetic Gastroparesis (DGP). Though it occurs in patients suffering from both Type-1 and Type- 2 diabetes, it is more common in female patients suffering from Type-2 diabetes. The cause of DGP is inherent damage in the vagus nerve that c…